伴有BCR::JAK2融合的骨髓增殖性肿瘤进展为谱系不明的急性白血病。 - Suppr

Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage.

作者信息

Suárez Edwin Uriel, Piris Miguel Ángel, Rodríguez-Pinilla Socorro María, García Juan F, López-Lorenzo José Luis, Cornago-Navascués Javier, Salgado-Sánchez Rocío, Castaño-Bonilla Tamara, Mata-Serna Raquel, Alonso-Domínguez Juan M, Llamas Pilar

机构信息

Department of Hematology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain.

Department of Pathology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain.

出版信息

Ann Hematol. 2024 May;103(5):1797-1799. doi: 10.1007/s00277-024-05647-6. Epub 2024 Feb 3.

DOI:10.1007/s00277-024-05647-6

PMID:38308706

Abstract

摘要

相似文献

Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage.伴有BCR::JAK2融合的骨髓增殖性肿瘤进展为谱系不明的急性白血病。

Ann Hematol. 2024 May;103(5):1797-1799. doi: 10.1007/s00277-024-05647-6. Epub 2024 Feb 3.

BCR-JAK2 fusion in a myeloproliferative neoplasm with associated eosinophilia.伴有嗜酸性粒细胞增多的骨髓增殖性肿瘤中的BCR-JAK2融合

Cancer Genet. 2016 May;209(5):223-8. doi: 10.1016/j.cancergen.2016.03.002. Epub 2016 Apr 6.

Myeloid neoplasm with eosinophilia and BCR-JAK2/t(9;22)(p24;q11.2) morphologically mimicking chronic myeloid leukemia.伴有嗜酸性粒细胞增多及BCR-JAK2/t(9;22)(p24;q11.2)的髓系肿瘤，形态学上酷似慢性髓系白血病。

Ann Diagn Pathol. 2020 Feb;44:151405. doi: 10.1016/j.anndiagpath.2019.151405. Epub 2019 Nov 14.

Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group.伴有 BCR-ABL1 易位和 JAK2 V617F 突变的骨髓增殖性肿瘤：来自骨髓病理学组的多机构研究。

Mod Pathol. 2018 May;31(5):690-704. doi: 10.1038/modpathol.2017.182. Epub 2018 Jan 12.

Acquisition of genomic events leading to lymphoblastic transformation in a rare case of myeloproliferative neoplasm with BCR-JAK2 fusion transcript.在一例罕见的伴有BCR-JAK2融合转录本的骨髓增殖性肿瘤中导致淋巴细胞转化的基因组事件的获得。

Eur J Haematol. 2016 Oct;97(4):399-402. doi: 10.1111/ejh.12752. Epub 2016 Mar 26.

Two alternatively spliced 5'BCR/3'JAK2 fusion transcripts in a myeloproliferative neoplasm with a three-way t(9;18;22)(p23;p11.3;q11.2) translocation.在一例伴有t(9;18;22)(p23;p11.3;q11.2) 三向易位的骨髓增殖性肿瘤中发现的两种选择性剪接的5'BCR/3'JAK2融合转录本

Cancer Genet. 2011 Sep;204(9):512-5. doi: 10.1016/j.cancergen.2011.08.016.

Chronic myeloproliferative neoplasm with concurrent BCR-ABL translocation and JAK2 mutation.伴有BCR-ABL易位和JAK2突变的慢性骨髓增殖性肿瘤

J Coll Physicians Surg Pak. 2010 Jun;20(6):423.

Concurrent JAK2-Positive Myeloproliferative Disorder and Chronic Myelogenous Leukemia: A Novel Entity? A Case Report With Review of the Literature.并发JAK2阳性骨髓增殖性疾病和慢性粒细胞白血病：一种新的实体？一例病例报告并文献复习

J Investig Med High Impact Case Rep. 2019 Jan-Dec;7:2324709619832322. doi: 10.1177/2324709619832322.

A BCR-JAK2 fusion gene from ins(22;9)(q11;p13p24) in a patient with atypical chronic myeloid leukemia.一名非典型慢性髓性白血病患者中源自ins(22;9)(q11;p13p24)的BCR-JAK2融合基因。

Leuk Lymphoma. 2013 Oct;54(10):2322-4. doi: 10.3109/10428194.2012.762648.

BCR/ABL-negative chronic myeloproliferative disorders: JAK2 mutation and beyond.BCR/ABL阴性慢性骨髓增殖性疾病：JAK2突变及其他相关情况。

Arch Pathol Lab Med. 2006 Aug;130(8):1123-5. doi: 10.5858/2006-130-1123-ACMD.

本文引用的文献

Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm.急变期骨髓增殖性肿瘤：当代综述与 2024 年治疗算法。

Blood Cancer J. 2023 Jul 18;13(1):108. doi: 10.1038/s41408-023-00878-8.

Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort.伴有嗜酸性粒细胞增多和酪氨酸激酶基因融合的髓系/淋巴系肿瘤：基于登记处队列的重新评估定义特征。

Leukemia. 2023 Sep;37(9):1860-1867. doi: 10.1038/s41375-023-01958-1. Epub 2023 Jul 15.

Updates on eosinophilic disorders.嗜酸性粒细胞疾病的最新进展。

Virchows Arch. 2023 Jan;482(1):85-97. doi: 10.1007/s00428-022-03402-8. Epub 2022 Sep 7.

Single-cell analysis of acute lymphoblastic and lineage-ambiguous leukemia: approaches and molecular insights.急性淋巴细胞白血病和谱系模糊白血病的单细胞分析：方法和分子见解。

Blood. 2023 Jan 26;141(4):356-368. doi: 10.1182/blood.2022016954.

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.国际髓系肿瘤和急性白血病分类：整合形态学、临床和基因组数据。

Blood. 2022 Sep 15;140(11):1200-1228. doi: 10.1182/blood.2022015850.

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.世界卫生组织血液淋巴肿瘤分类第五版：髓系和组织细胞/树突状肿瘤。

Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.

Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance.骨髓增殖性肿瘤伴 BCR-JAK2 治疗后出现淋巴母细胞样转化：耐药的推测机制。

Blood Adv. 2021 Sep 14;5(17):3492-3496. doi: 10.1182/bloodadvances.2020004174.

Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2.伴嗜酸性粒细胞增多和 PDGFRA、PDGFRB 或 FGFR1 重排或伴 PCM1-JAK2 的髓系/淋系肿瘤

Am J Clin Pathol. 2021 Feb 4;155(2):160-178. doi: 10.1093/ajcp/aqaa208.

Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.针对与 PCM1-JAK2、BCR-JAK2 和 ETV6-ABL1 融合基因相关的髓系肿瘤对酪氨酸激酶抑制剂的反应。

Am J Hematol. 2020 Jul;95(7):824-833. doi: 10.1002/ajh.25825. Epub 2020 Apr 28.

Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study.具有 9p24/JAK2 重排的造血系统肿瘤：一项多中心研究。

Mod Pathol. 2019 Apr;32(4):490-498. doi: 10.1038/s41379-018-0165-9. Epub 2018 Nov 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献